Thu | Dec 2, 2021

WHO grants emergency use of J&J vaccine

Published:Friday | March 12, 2021 | 2:58 PM
This October 16, 2012 file photo shows the Johnson & Johnson logo on a package of Band-Aids in St. Petersburg, Florida. The World Health Organization on Friday, March 12, 2021, granted an emergency use listing for the coronavirus vaccine made by Johnson & Johnson, meaning the one-dose shot can now theoretically be used as part of the international COVAX effort to distribute vaccines globally, including to poor countries without any supplies. (AP Photo/Chris O'Meara, File)

GENEVA — The World Health Organization granted an emergency use listing for the coronavirus vaccine made by Johnson & Johnson, meaning the one-dose shot can be used as part of the international COVAX effort to distribute vaccines globally, including to developing countries with no supplies.

In a statement on Friday, the WHO said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations.

The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

The US Food and Drug Administration granted the J&J vaccine emergency authorisation last month.

A massive study that spanned three continents found the J&J vaccine was 85% effective in protecting against severe illness, hospitalisation, and death.

That protection remained strong even in countries such as South Africa with variants.

The UN-backed COVAX effort previously announced it had an initial agreement with J&J to provide 500 million doses, but it’s not legally binding.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.